The off-label use of ketamine to treat chronic pain is not supported by scientific evidence, a new Cochrane review has found.

The Ministry of Health, through the Pharmacy and Poisons Board, has cautioned the public against the off-label use of ...

Off-label use is of concern when there is evidence on the low effectiveness or high risks associated with the use of a drug for a non-approved condition, and yet, it is regularly used.

Doctors routinely (and legally) prescribe drugs "off label"—that is, for conditions not approved by the FDA—for any use they see fit. Most don't tell their patients.

They were written by 174 Quebec doctors. According to the study, trazodone was the most common off-label use for antidepressants. It’s often prescribed to help people sleep.

The latest research on off-label uses of GLP-1 drugs While some GLP-1 drugs have FDA approval for treatment of Type 2 diabetes and/or obesity, doctors have found that they may also help treat ...

Off-label uses and other repurposing efforts don’t come without health risks as the discussion surrounding Trump’s hydroxychloroquine revealed. France is now banning the use of hydroxychloroquine.

Harnessing Public Interest To Improve Pediatric Off-Label Drug Use At Long Last Theresa Kudlick August 1, 2022 10.1377/forefront.20220728.518149 Add to favorites ...

“Off-label prescribing is common, but it is really unclear in this case what physicians would be able to do.” The risk doctors run could vary state-to-state.

J. Joseph V. Gulfo’s “Ending the Prescribe-Don’t-Tell Charade for Off-Label Drugs” (op-ed, March 28) describes the status of off-label drug prescription drugs with respect to advertising ...